Literature DB >> 1883315

Regulation of nuclear histone acetyltransferase by nucleic acids, histone.DNA complex, and chromatin.

L J Wong1, D J Sharpe.   

Abstract

Nuclear histone acetyltransferase is found to be inhibited by various nucleic acids and components. Of the adenosine phosphates, the order of inhibitory potency is ATP greater than ADP greater than AMP. Among the nucleoside triphosphates, GTP seems to be the best inhibitor, followed by ATP, CTP, and UTP. Deoxymononucleotides have the same order of inhibition potential as their ribonucleotide counterparts, with inhibition constants in the low millimolar range. Oligonucleotides and polynucleotides are much better inhibitors than mononucleotides. The inhibition constants of the DNA molecules are size dependent. Molecules larger than 40 base pairs have inhibition constants less than 18 micrograms/ml, whereas molecules with decreasing numbers of base pairs have increasing magnitudes of inhibition constants. However, acetyltransferase has a lower affinity for free DNA molecules than for DNA.histone complexes as revealed by its interaction with DNA-Sepharose and histone.DNA-Sepharose columns. Furthermore, native chromatin depleted of endogenous histone acetyltransferase activity shows no inhibitory effect on the enzyme. Yet heated chromatin not only loses substrate activity but also becomes an inhibitor for the enzyme. Since unmodified sea urchin sperm chromatin has been shown to be a potent acetyltransferase inhibitor, it seems possible that DNA.histone complexes may be the true inhibitory species and that the conformational states of such complexes may serve as a regulatory mechanism in the control of the enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883315     DOI: 10.1007/bf00578236

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  21 in total

1.  Studies on highly metabolically active acetylation and phosphorylation of histones.

Authors:  V Jackson; A Shires; R Chalkley; D K Granner
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

2.  Acetylated histone H4 is preferentially associated with template-active chromatin.

Authors:  J R Davie; E P Candido
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Transcription of ribonucleic acid in isolated mouse myeloma nuclei.

Authors:  W F Marzluff; E C Murphy; R C Huang
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

4.  Nucleosome-histone acetyltransferase from rat liver chromatin.

Authors:  M Fukushima; K Ota; D Fujimoto; K Horiuchi
Journal:  Biochem Biophys Res Commun       Date:  1980-02-27       Impact factor: 3.575

5.  Effect of sea urchin sperm chromatin on histone acetylation.

Authors:  L J Wong
Journal:  Biochem Biophys Res Commun       Date:  1980-12-31       Impact factor: 3.575

6.  Comparative studies of histone acetylation in nucleosomes, nuclei, and intact cells. Evidence for special factors which modify acetylase action.

Authors:  R L Garcea; B M Alberts
Journal:  J Biol Chem       Date:  1980-12-10       Impact factor: 5.157

7.  Structure of chromatin containing extensively acetylated H3 and H4.

Authors:  R T Simpson
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

8.  Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences.

Authors:  G Vidali; L C Boffa; E M Bradbury; V G Allfrey
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  The use of DNA-cellulose for analyzing histone-DNA interactions. Discovery of nucleosome-like histone binding to single-stranded DNA.

Authors:  K B Palter; B M Alberts
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

10.  A direct link between core histone acetylation and transcriptionally active chromatin.

Authors:  T R Hebbes; A W Thorne; C Crane-Robinson
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.